Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX)

CUSIP: 09203E105

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
58,000,000
Total 13F shares
22,285,008
Share change
+22,285,008
Total reported value
$555,219,061
Price per share
$24.95
Number of holders
65
Value change
+$555,219,061
Number of buys
65

Quarterly Holders Quick Answers

What is CUSIP 09203E105?
CUSIP 09203E105 identifies BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX) as of Q1 2020

As of 31 Mar 2020, Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,285,008 shares. The largest 10 holders included NEA Management Company, LLC, RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, Artal Group S.A., FMR LLC, Bellevue Group AG, WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, and DRIEHAUS CAPITAL MANAGEMENT LLC. This page lists 65 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2020 vs Q4 2025 Across Filers

Q4 2025 holders
103
Q1 2020 holders
65
Holder diff
-38
Investor Q4 2025 Shares Q1 2020 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .